Pillars4Life Trial
CompletedNot applicableNCT02465892
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aims to explore whether cancer patients can benefit from completing the Pillars4Life online coping program. This randomized control trial will have half its subject completing the program and the other half receiving standard care in order to measure whether the program is beneficial in dealing with stress, anxiety, and particularly chronic pain that often accompany a cancer diagnosis.
Study details
- Official title
- Pillars4Life Randomized Control Trial
- Conditions
- Breast Cancer
- Lung Cancer
- Esophageal Cancer
- Colon Cancer
- Pancreatic Cancer
- Liver Cancer
- Renal Cancer
- Bladder Cancer
- Prostate Cancer
- Ovarian Cancer
- Cervical Cancer
- Uterine Cancer
- Interventions
- Behavioral: Pillars4Life
- Sponsor
- Duke University
- Collaborators
- Pfizer
- Start date
- 2015-05
- Primary completion
- 2016-10
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Current pain level ≥3 and at least one prior score ≥3 on a 0-10 scale as reported in EPIC; * Age ≥18 years * Diagnosed with Breast, GI, GU, GYN, or Thoracic cancer * Actively receiving care at the Duke Cancer Center, Durham Regional Hospital, or Duke Raleigh Hospital * Able/willing to have an online interaction with the Pillars4Life online CORE program curriculum * Life expectancy ≥6 months * Providing informed consent * Able to read/write English. Exclusion Criteria: * none
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02465892